Staff Publications: August 2017

  1. Abouassaly R, Bream MJ, Smaldone MC, et al. National Utilization of Regional Lymph Node Dissection among Patients with Kidney Cancer and Clinical Lymphadenopathy Undergoing Radical Nephrectomy. Cancer Treatment and Research Communications. 2017;12:14-18.
  2. Alpaugh RK, Zhou LL, Dicker DT, Matthew E, El-Deiry WS. Circulating Tumor Cells: Silent Predictors of Metastasis. F1000Research. 2017;6.
  3. Alvarez P, Jensen LE. Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner. Mediators Inflamm. 2016;2016:6756138. PMID: 28057979. PMC5183767.
  4. An Y, Doney AC, Andrade RB, Wheeler SE. Stacking Interactions between 9-Methyladenine and Heterocycles Commonly Found in Pharmaceuticals. J Chem Inf Model. 2016;56(5):906-914. PMID: 27074615.
  5. Anthony SA, Burrell AL, Johnson MC, et al. Reconstituted IMPDH Polymers Accommodate Both Catalytically Active and Inactive Conformations. Mol Biol Cell. 2017. PMID: 28794265. PMC5620369.
  6. Astsaturov I. Future Clinical Trials: Genetically Driven Trials. Surg Oncol Clin N Am. 2017;26(4):791-797. PMID: 28923231. PMC5645064.
  7. Belinsky MG, Cai KQ, Zhou Y, et al. Succinate Dehydrogenase Deficiency in a PDGFRA Mutated GIST. BMC Cancer. 2017;17(1):512. PMID: 28768491. PMC5541693.
  8. Boland PM, Meyer JE, Berger AC, et al. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017;40(4):393-398. PMID: 26986978. PMC5026539. NIHMS640074.
  9. Boyle SM, Ali N, Olszanski AJ, et al. Donor-Derived Metastatic Melanoma and Checkpoint Inhibition. Transplant Proc. 2017;49(7):1551-1554. PMID: 28838438.
  10. Cahn DB, Handorf E, Ristau BT, et al. Contemporary Practice Patterns and Survival Outcomes for Locally Advanced Urethral Malignancies: A National Cancer Database Analysis. Urol Oncol. 2017;35(12):670 e615-670 e621. PMID: 28803701.
  11. Chakhtoura M, Sriram U, Heayn M, et al. Bisphenol a Does Not Mimic Estrogen in the Promotion of the in Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands. Mediators Inflamm. 2017;2017:2034348. PMID: 28811679. PMC5547709.
  12. Chen VS, Abouassaly R, Gonzalez CM, et al. Association of Race and Margin Status among Patients Undergoing Robotic Partial Nephrectomy for T1 Renal Cell Carcinoma: Results from a Population-Based Cohort. Urol Oncol. 2017;35(11):662 e617-662 e621. PMID: 28781110.
  13. Dalton BGA, Friedant AJ, Su S, Schatz TAP, Ruth KJ, Scott WJ. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer. J Laparoendosc Adv Surg Tech A. 2017;27(12):1279-1283. PMID: 28777676.
  14. Dans M, Smith T, Back A, et al. NCCN Guidelines Insights: Palliative Care, Version 2.2017. J Natl Compr Canc Netw. 2017;15(8):989-997. PMID: 28784860.
  15. Di Meco A, Li JG, Blass BE, Abou-Gharbia M, Lauretti E, Pratico D. 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice. Biol Psychiatry. 2017;81(2):92-100. PMID: 27499089.
  16. Dong Y, Li T, Churilla TM, et al. Impact of Rheumatoid Arthritis on Radiation-Related Toxicity and Cosmesis in Breast Cancer Patients: A Contemporary Matched-Pair Analysis. Breast Cancer Res Treat. 2017;166(3):787-791. PMID: 28825145.
  17. Dotan E. Advancing Treatment Approach to the Older Patient with Cancer through Clinical Trials Participation. Surgical Oncology Clinics of North America. 2017;26(4):719-728. PMID: 28923227
  18. Dotan E, Cohen SJ, Starodub AN, et al. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients with Refractory or Relapsing Metastatic Colorectal Cancer. J Clin Oncol. 2017;35(29):3338-3346. PMID: 28817371.
  19. Epperla N, Maddocks KJ, Salhab M, et al. C-MYC-Positive Relapsed and Refractory, Diffuse Large B-Cell Lymphoma: Impact of Additional “Hits” and Outcomes with Subsequent Therapy. Cancer. 2017;123(22):4411-4418. PMID: 28749548.
  20. Fakhry C, Zhang Q, Nguyen-Tan PF, et al. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients with Oropharyngeal Cancer. J Clin Oncol. 2017;35(36):4057-4065. PMID: 28777690. PMC5736236.
  21. Finelli A, Ismaila N, Bro B, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(6):668-680. PMID: 28095147.
  22. Goel N, Reddy SS. Randomized Clinical Trials in Pancreatic Cancer. Surg Oncol Clin N Am. 2017;26(4):767-790. PMID: 28923230.
  23. Gokare P, Finnberg NK, Abbosh PH, Dai J, Murphy ME, El-Deiry WS. P53 Represses Pyrimidine Catabolic Gene Dihydropyrimidine Dehydrogenase (DPYD) Expression in Response to Thymidylate Synthase (TS) Targeting. Sci Rep. 2017;7(1):9711. PMID: 28851987. PMC5575263.
  24. Gokare P, Lulla AR, El-Deiry WS. MMR-Deficiency and BRCA2/EGFR/NTRK Mutations. Aging (Albany NY). 2017;9(8):1849-1850. PMID: 28783711. PMC5611973.
  25. Gupta MK, Kaminski R, Mullen B, et al. HIV-1 NEF-Induced Cardiotoxicity through Dysregulation of Autophagy. Sci Rep. 2017;7(1):8572. PMID: 28819214. PMC5561171.
  26. Gutierrez Diez PJ, Su Y, Russo J. Immunocytochemical Stem Cell Markers Can Predict Clinical Stage of Breast Cancer. Oncol Rep. 2017;38(3):1507-1516. PMID: 28714035.
  27. Hall MJ, Forman AD, Obeid E. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste. JAMA Oncol. 2017;3(12):1739-1740. PMID: 28837713.
  28. Hoang TM, Kent T, Pomerantz RT. Modification of 3′ Terminal Ends of DNA and RNA Using DNA Polymerase Theta Terminal Transferase Activity. Bio Protoc. 2017;7(12). PMID: 28824932. PMC5560110. NIHMS888405.
  29. Huo J, Chu Y, Chamie K, et al. Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed with Bladder Cancer. Clin Genitourin Cancer. 2017. PMID: 28826932. PMC5878135.
  30. Jalal SI, Hanna N, Zon R, et al. Phase I Study of Amrubicin and Cyclophosphamide in Patients with Advanced Solid Organ Malignancies: HOG LUN 07-130. Am J Clin Oncol. 2017;40(4):329-335. PMID: 25503432.
  31. Jensen LE. Interleukin-36 Cytokines May Overcome Microbial Immune Evasion Strategies That Inhibit Interleukin-1 Family Signaling. Sci Signal. 2017;10(492). PMID: 28811383.
  32. Kantarjian HM, Roboz GJ, Kropf PL, et al. Guadecitabine (SGI-110) in Treatment-Naive Patients with Acute Myeloid Leukaemia: Phase 2 Results from a Multicentre, Randomised, Phase 1/2 Trial. Lancet Oncol. 2017;18(10):1317-1326. PMID: 28844816. PMC5925750.
  33. Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. J Am Coll Cardiol. 2017;69(25):3084-3098. PMID: 28641798. PMC5512584. NIHMS876379.
  34. Lee M, Zhu L, Wang MQ, et al. Psychosocial Predictors of HBV Screening Behavior among Vietnamese Americans. Am J Health Behav. 2017;41(5):561-570. PMID: 28760178. PMC5633084.
  35. Li K, Wen M, Henry KA. Ethnic Density, Immigrant Enclaves, and Latino Health Risks: A Propensity Score Matching Approach. Soc Sci Med. 2017;189:44-52. PMID: 28780439. PMC5573190. NIHMS897740.
  36. Liu Y, von Mehren M. Randomized Clinical Trials in Gastrointestinal Stromal Tumors. Surg Oncol Clin N Am. 2017;26(4):545-557. PMID: 28923219.
  37. Lucas JW, Lester KM, Chen A, Simhan J. Scrotal Reconstruction and Testicular Prosthetics. Transl Androl Urol. 2017;6(4):710-721. PMID: 28904904. PMC5583055.
  38. Lynch SM, Mitra N, Ross M, et al. A Neighborhood-Wide Association Study (Nwas): Example of Prostate Cancer Aggressiveness. PLoS One. 2017;12(3):e0174548. PMID: 28346484. PMC5367705.
  39. Maggiore RJ, Dale W, Hurria A, et al. Hematology-Oncology Fellows’ Training in Geriatrics and Geriatric Oncology: Findings from an American Society of Clinical Oncology-Sponsored National Survey. J Oncol Pract. 2017;13(11):e900-e908. PMID: 28837375.
  40. Martin LP, Konner JA, Moore KN, et al. Characterization of Folate Receptor Alpha (FRα) Expression in Archival Tumor and Biopsy Samples from Relapsed Epithelial Ovarian Cancer Patients: A Phase I Expansion Study of the FRα-Targeting Antibody-Drug Conjugate Mirvetuximab Soravtansine. Gynecol Oncol. 2017;147(2):402-407. PMID: 28843653.
  41. Mortazavi S, Bevelacqua JJ, Corrice L, et al. Comment on “Chromosomal Aberrations in Large Japanese Field Mice (Apodemus Speciosus) Captured near Fukushima Dai-Ichi Nuclear Power Plant”. Environ Sci Technol. 2017;51(14):8196-8197. PMID: 28654249.
  42. Mortazavi SMJ, Mortazavi SAR, Paknahad M. Evaluation of the Potential of Mobile Phone Specific Electromagnetic Fields (UMTS) to Produce Micronuclei in Human Glioblastoma Cell Lines. Toxicol In Vitro. 2017;44:414-415. PMID: 28778768.
  43. Newman LA, Stark A, Chitale D, et al. Association between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. JAMA Oncol. 2017;3(8):1102-1106. PMID: 28006062. PMC5796807.
  44. Nizovtseva EV, Todolli S, Olson WK, Studitsky VM. Towards Quantitative Analysis of Gene Regulation by Enhancers. Epigenomics. 2017;9(9):1219-1231. PMID: 28799793. PMC5585842.
  45. Patt YZ, Murad W, Fekrazad MH, et al. INST OX-05-024: First Line Gemcitabine, Oxaliplatin, and Erlotinib for Primary Hepatocellular Carcinoma and Bile Duct Cancers: A Multicenter Phase II Trial. Cancer Med. 2017;6(9):2042-2051. PMID: 28801995. PMC5603839.
  46. Prabhu VV, Lulla AR, Madhukar NS, et al. Cancer Stem Cell-Related Gene Expression as a Potential Biomarker of Response for First-in-Class Imipridone ONC201 in Solid Tumors. PLoS One. 2017;12(8):e0180541. PMID: 28767654. PMC5540272.
  47. Ramamurthy C, Chertock Y, Hall MJ. Randomized Controlled Trials in Hereditary Cancer Syndromes. Surg Oncol Clin N Am. 2017;26(4):729-750. PMID: 28923228.
  48. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016:1359105316671188. PMID: 28810355. PMC5561513. NIHMS834324.
  49. Sakai K, Sanders KM, Youssef MR, et al. Role of Neurturin in Spontaneous Itch and Increased Nonpeptidergic Intraepidermal Fiber Density in a Mouse Model of Psoriasis. Pain. 2017;158(11):2196-2202. PMID: 28825602. PMC5676563.
  50. Shah JJ, Kaufman JL, Zonder JA, et al. A Phase 1 and 2 Study of Filanesib Alone and in Combination with Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma. Cancer. 2017;123(23):4617-4630. PMID: 28817190. PMC5856158.
  51. Shipley ST, Johnson DK, Roodgar M, et al. Mycobacterium Kansasii Isolated from Tuberculinpositive Rhesus Macaques (Macaca Mulatta) in the Absence of Disease. Comp Med. 2017;67(4):368-375. PMID: 28830585. PMC5557210.
  52. Simmons RA, Cosgrove SC, Romney MC, et al. Health Literacy: Cancer Prevention Strategies for Early Adults. Am J Prev Med. 2017;53(3S1):S73-S77. PMID: 28818249.
  53. Sultanov DC, Gerasimova NS, Kudryashova KS, et al. Unfolding of Core Nucleosomes by PARP-1 Revealed by spFRET Microscopy. AIMS Genet. 2017;4(1):21-31. PMID: 28804761. PMC5552189. NIHMS889070.
  54. Sznol M, Postow MA, Davies MJ, et al. Endocrine-Related Adverse Events Associated with Immune Checkpoint Blockade and Expert Insights on Their Management. Cancer Treat Rev. 2017;58:70-76. PMID: 28689073.
  55. Tan Y, Sementino E, Chernoff J, Testa JR. Targeting MYC Sensitizes Malignant Mesothelioma Cells to PAK Blockage-Induced Cytotoxicity. Am J Cancer Res. 2017;7(8):1724-1737. PMID: 28861328. PMC5574944.
  56. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(8):1028-1061. PMID: 28784865.
  57. Thompson MD, Lubet RA, McCormick DL, et al. Lack of Chemopreventive Efficacy of Metformin in Rodent Models of Urinary Bladder, Head and Neck, and Colon/Intestine Cancer. Oncol Lett. 2017;14(3):3480-3486. PMID: 28927103. PMC5587978.
  58. Troupes CD, Wallner M, Borghetti G, et al. Role of STIM1 (Stromal Interaction Molecule 1) in Hypertrophy-Related Contractile Dysfunction. Circ Res. 2017;121(2):125-136. PMID: 28592415. PMC5531450. NIHMS883225.
  59. Tursi SA, Lee EY, Medeiros NJ, et al. Bacterial Amyloid Curli Acts as a Carrier for DNA to Elicit an Autoimmune Response via TLR2 and TLR9. PLoS Pathog. 2017;13(4):e1006315. PMID: 28410407. PMC5406031.
  60. 60. Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and Adjuvant Radiation for High-Risk Skin Adnexal Carcinoma of the Head and Neck. Am J Clin Oncol. 2017;40(4):429-432. PMID: 25599317. PMC4504824. NIHMS648261.
  61. Wang TP, Doss M, Tokar JL, Reddy S, Barta SK, Yu JQ. Lymphoma Causing Gastrosplenic Fistula Revealed by FDG PET/CT. Clin Nucl Med. 2017;42(11):890-892. PMID: 28806244.
  62. Weng YL, An R, Cassin J, et al. An Intrinsic Epigenetic Barrier for Functional Axon Regeneration. Neuron. 2017;94(2):337-346 e336. PMID: 28426967. PMC6007997.
  63. Xiao Q, Sherman SE, Wilner SE, et al. Janus Dendrimersomes Coassembled from Fluorinated, Hydrogenated, and Hybrid Janus Dendrimers as Models for Cell Fusion and Fission. Proc Natl Acad Sci USA. 2017;114(34):E7045-E7053. PMID: 28784782. PMC5576825.
  64. Xu B, Chakraborty H, Yadav VK, Zhang Z, Klein ML, Ren S. Tunable Two-Dimensional Interfacial Coupling in Molecular Heterostructures. Nat Commun. 2017;8(1):312. PMID: 28827651. PMC5567094.
  65. Xu J, Lee MH, Chakhtoura M, et al. Stat2 Is Required for TLR-Induced Murine Dendritic Cell Activation and Cross-Presentation. J Immunol. 2016;197(1):326-336. PMID: 27233962. PMC4912940. NIHMS785183.
  66. Yadav RK, Jablonowski CM, Fernandez AG, et al. Histone H3G34R Mutation Causes Replication Stress, Homologous Recombination Defects and Genomic Instability in S. Pombe. eLife. 2017;6. PMID: 28718400. PMC5515577.
  67. Zaorsky NG, Lee CT, Zhang E, Keith SW, Galloway TJ. Hypofractionated Radiation Therapy for Basal and Squamous Cell Skin Cancer: A Meta-Analysis. Radiother Oncol. 2017;125(1):13-20. PMID: 28843727.
  68. Zhou G, Pantelopulos GA, Mukherjee S, Voelz VA. Bridging Microscopic and Macroscopic Mechanisms of P53-MDM2 Binding with Kinetic Network Models. Biophys J. 2017;113(4):785-793. PMID: 28834715. PMC5567610.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s